Former Texas Governor and incoming Secretary of the U.S. Department of Energy, Rick Perry, has resigned from the board of directors of Houston-based biotechnology company, Celltex Therapeutics Corporation, as is customary of an individual serving on the U.S. Cabinet.
“On behalf of Celltex Therapeutics, I want to thank Rick Perry for his contributions to our company and wish him all the best as he focuses on his new role as Energy Secretary,” says Celltex Chairman and CEO David Eller.
Celltex uses proprietary technology, which isolates, multiplies and banks autologous (one’s own) adult mesenchymal stem cells (MSCs) to be used for regenerative therapy for injuries and chronic pain as well as a number of conditions, including vascular, degenerative and autoimmune diseases.
As the 47th and longest-serving governor of the Lone Star State, Perry championed the advancement of adult stem cell therapy during his time in office and became one of the first clients of Celltex in 2011.
During his time as governor of the State of Texas, he worked to advance stem cell science within the appropriate scientific, ethical and regulatory framework and, under his leadership, the Texas Medical Board passed a rule setting forth guidelines for supervising the use of stem cells for the first time in history. His advocacy also allowed the State of Texas to provide funds to bring scientists to Texas and Texas institutions, and created a climate that allowed Celltex to bring its technology to Americans.
About Celltex Therapeutics Corporation
Celltex is a Houston-based biotechnology company that is leading the United States into the future of adult stem cell therapy with its proprietary technology. Celltex is committed to expanding the use of adult stem cell therapy by a licensed physician, with the goal of securing the future of regenerative medicine in the United States. For more information about Celltex Therapeutics Corporation, please visit www.celltexbank.com.